Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 31, 2008

View Archived Issues

Recent Japanese patents describe new agents for endocrine-related disorders

Novel antiinfective agents disclosed in recent patent literature

New immmunosuppressants for preventing transplant rejection reported in recent Rigel patent

Hsp90 inhibitor MPC-3100 active in tumor models

PROTECT-1: 45% clinical remission rate with CCX-282-B in Crohn's disease patients

Parion and Kainos sign clinical development agreement for dry mouth treatment P-552

Allergan and Spectrum collaborate on apaziquone development

Phase I data on Millennium's Aurora A kinase inhibitors available

GlaxoSmithKline to acquire Genelabs Technologies

Radezolid and linezolid equally effective in uncomplicated skin and skin structure infections

DAC initiates phase I/IIa clinical trial of DAC-0060 in non-melanoma skin cancers

Lpath and Merck Serono sign worldwide license agreement for ASONEP monoclonal antibody

Alvine reports results from phase I clinical trial of ALV-003 in celiac disease

Nabi reports final results from phase II immunogenicity study of NicVAX

Snapshots: ACCESS, CHARM, CARE results for adalimumab in Crohn's disease

Preclinical data on D-3263 show anticancer potential of TrpM8 agonism

SuperGen reports on development of JAK2 inhibitor SGI-1252

Karo's phase II study expands the potential for eprotirome in dyslipidemia

Morria presents preliminary results from phase II allergic rhinitis study

Telik reports top-line results from Assist-5 trial in ovarian cancer

Infinity expands phase II study of IPI-504 in advanced non-small cell lung cancer

Takeda submits NDA for Actos combination tablet in Japan

FDA accepts for priority review ImClone and Bristol-Myers' sBLA for Erbitux

FDA grants orphan drug status to Aldagen's ALD-101 stem cell therapy

Patient enrollment complete in RES-ELUTION I trial of Cordis and Conor Medsytems' Nevo stent

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...